The Japanese neurovascular device market will see strong growth through 2032. New device launches, increasing adoption of innovative devices backed by favorable clinical data, and rising…
The impact of the COVID-19 pandemic on the Japanese trauma device market was relatively lesser due to the urgent nature of the procedures involved. Going forward, market growth will be supported by…
The Japanese interventional oncology device market will grow slowly due to limited adoption of minimally invasive interventional oncology procedures, substantiated by Japanese guidelines and…
The Japanese EP mapping and ablation device market has recovered largely from the COVID-19 pandemic and will resume moderate growth over the remainder of the forecast period, supported by…
The Japanese IC device market is driven by an expanding CAD patient pool, the growing prevalence of complex lesions, improving access to treatment, the emerging preference for minimally invasive…
The impact of COVID-19 pandemic was significant on the Japanese large-joint reconstructive implant market, limiting hip and knee replacement procedures and unit sales. Following which, favorable…
The Japanese ENT device market was severely impacted by the COVID-19 pandemic in 2020, but it has since shown significant recovery and is anticipated to return to prepandemic trends in the coming…
The Japanese GI endoscopy device market was impacted negatively by the COVID-19 global pandemic, resulting in declines in procedure volumes, units sold, and overall market value in 2020. The market…
The global COVID-19 pandemic negatively impacted the Japanese heart valve device market to some extent. However, in the longer term, the market will be driven by positive results from THV device…
While the COVID-19 pandemic has significantly impacted the market in the short term, other factors, such as favorable demographics, will drive market growth once the impact of the pandemic has…
COVID-19 has negatively impacted the Japan transcatheter embolization and occlusion device market, but the impact of COVID-19 is limited and short term, the market will expand at a moderate rate…
The Japanese laparoscopic device market was negatively impacted by the COVID-19 pandemic. However, the overall market for laparoscopic devices will exhibit modest growth over the forecast period,…
The Japanese dialysis access treatment device market will be driven by significant rise in ESRD population and will grow modestly through 2031. New product launches such as DCB, DES, and…
Growing adoption of premium-priced DES and DCBs will be fueled by the continued emergence of data supporting the safety of paclitaxel-coated devices, resulting in modest growth in the Japanese PV…
Despite the negative—albeit relatively limited—impact of the ongoing COVID-19 pandemic, the Japanese aortic repair device market will grow at a modest rate, which in turn is attributed to shift…